إعلان
إعلان
VTGN
Vistagen Therapeutics, Inc. Common Stock
0.74
USDبرعاية
+0.02
+2.55%
٠٧ يناير, ١٦:٠٠ UTC -5
مغلق
بعد الإغلاق
0.74
0.00
+0.27%
تقارير أرباح VTGN
النسبة الإيجابية المفاجئة
VTGN تفوق 19 من 37 آخر التقديرات.
51%
التقرير التالي
بيانات التقرير القادم
١١ فبراير ٢٠٢٦
Estimate for Q3 26 (Revenue/ EPS)
$373.32K
/-$0.48
التغير الضمني من Q2 26 (Revenue/ EPS)
+44.70%
/-11.11%
التغير الضمني من Q3 25 (Revenue/ EPS)
+59.54%
/+4.35%
Vistagen Therapeutics, Inc. Common Stock earnings per share and revenue
On ١٣ نوفمبر ٢٠٢٥, VTGN reported earnings of -0.54 USD per share (EPS) for Q2 26, missing the estimate of -0.48 USD, resulting in a -11.23% surprise. Revenue reached 258.00 ألف, compared to an expected 248.20 ألف, with a 3.95% difference. The market reacted with a 0.00% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 7 المحللين forecast an EPS of -0.48 USD, with revenue projected to reach 373.32 ألف USD, implying an نقصان of -11.11% EPS, and زيادة of 44.70% in Revenue from the last quarter.
الأسئلة الشائعة
What were Vistagen Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Vistagen Therapeutics, Inc. Common Stock reported EPS of -$0.54, missing estimates by -11.23%, and revenue of $258.00K, 3.95% above expectations.
How did the market react to Vistagen Therapeutics, Inc. Common Stock's Q2 2026 earnings?
The stock price moved -- 0%, changed from $3.80 before the earnings release to $3.80 the day after.
When is Vistagen Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for ١١ فبراير ٢٠٢٦.
What are the forecasts for Vistagen Therapeutics, Inc. Common Stock's next earnings report?
Based on 7
المحللين, Vistagen Therapeutics, Inc. Common Stock is expected to report EPS of -$0.48 and revenue of $373.32K for Q3 2026.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان